2Marshall SM. Recent advances in diabetic nephropathy[J].Clinical Medicine,2004,(03):277-282.
3Yilmaz N,Cicek HK,Celik A. Diagnostic value of homocysteine,C-reactive protein and bilirubin for coronary artery disease[J].Eastern Mediterranean Health Journal,2007,(03):522-535.
4UK Prospective Diabetes Study(UKPDS)Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33)[J].The Lancet,1998,(9131):837-853.doi:10.1016/S0140-6736(98)07019-6.
5Hoogeveen EK,Kostense PJ,Jager A. Serum homocysteine level and protein intake are related to risk of microalbuminuria:the Hoorn study[J].Kidney International,1998,(01):203-209.
6Ozmen B,Ozmen D,Turgan N. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus[J].Annals of Clinical and Laboratory Science,2002,(03):279-286.
7Navarro JF,Mora C,Maca M. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus[J].American Journal of Kidney Diseases,2003,(01):53-61.
8Pradhan AD,Manson JE,Rifai N. C-reactive protein.interleukin 6,and risk of developing type 2 diabetes mellitus[J].Journal of the American Medical Association,2001,(03):327-334.
9Barzilay JI,Abraham L,Heckbert SR. The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study[J].Diabetes,2001,(10):2384-2389.
10Kolset SO,Reinholt FP,Jenssen T.Diabetic nephropathy and extracellular matrix[J].J Histochem Cytochem,2012,60(12):976-986.
